The 4-anilinoquinazoline class of inhibitors of the erbB family of receptor tyrosine kinases
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmaceutical Science
Reference35 articles.
1. Discovering novel chemotherapeutic drugs for the third millennium;Garrett;Eur. J. Cancer Special Issue,1999
2. Inhibition of the epidermal growth factor receptor family of tyrosine kinases as an approach to cancer chemotherapy: progression from reversible to irreversible inhibitors;Fry;Pharm. Ther.,1999
3. The epidermal growth factor receptor and its inhibition in cancer therapy;Woodburn;Pharm. Ther.,1999
4. Role of HER2 gene overexpression in breast carcinoma;Menard;J. Cell Physiol.,2000
5. The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis;Kim;Exp. Cell Res.,1999
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, synthesis, molecular docking, and evaluation of sulfonyl quinazoline analogues as promising liver cancer drugs;Bioorganic Chemistry;2024-12
2. Insights into Halogen-Induced Changes in 4-Anilinoquinazoline EGFR Inhibitors: A Computational Spectroscopic Study;Molecules;2024-06-12
3. CUDC‑101 is a potential target inhibitor for the EGFR‑overexpression bladder cancer cells;International Journal of Oncology;2023-10-12
4. Molecular modeling of 3‑chloro-3-phenylquinoline-2,4‑dione, crystal structure and cytotoxic activity for developments in a potential new drug;Journal of Molecular Structure;2023-07
5. Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVID;Archives of Microbiology;2023-05-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3